Marijuana Moment reports
The U.S. House of Representatives on Tuesday again defeated a spending bill amendment meant to promote research into the medical benefits of psychedelics like psilocybin and MDMA. But it picked up about 50 “yes” votes since it was last considered in 2019, signaling that Congress may be coming around on the issue as psychedelics reform advances at the state and local levels—similar to how support for marijuana law reform has increased over time.
Rep. Alexandria Ocasio-Cortez (D-NY) sponsored the amendment, with the hopes of attaching it to a wide-ranging appropriations bill. But it failed in a 140-285 vote. That’s a notably smaller margin compared to two years ago, when the proposal was rejected by a vote of 91-331.